TLSHAB
Telstra Group Limited
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
N/A
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
0
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
3.5% Notes Mat 03-Sep-2036 Min Cons $5Ht Nc
π Performance
Price History
N/A
1M
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in TLSHAB
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
N/A
β° Last time a customer invested in TLSHAB
N/A
TLSHAB investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in TLSHAB also invest in...
Want more shares? Try these...
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company develops a portfolio of clinical and commercial stage products that addresses significant unmet medical needs in oncology and rare diseases. The company operates a pipeline of theranostic radiopharmaceutical product candidates with a focus in urologic oncology (prostate and kidney), neuro-oncology (glioma), musculoskeletal oncology (sarcoma) and bone marrow conditioning. The company operates under four business units: Therapeutics, Precision Medicine (Diagnostics), Lightpoint (Medtech), and Telix Manufacturing Solutions (TMS). Its lead imaging product is gallium-68 (68Ga) gozetotide injection (also known as 68Ga PSMA-11 and marketed under the brand name Illuccix). Its other pipelines include TLX591, TLX592, TLX250, TLX250-CDx, TLX101, TLX101-CDx, TLX300, TLX300-CDx, TLX66, and TLX66-CDx.
π Performance (5Yr p.a)
229.50%
π Share price
$22.58 AUD
𧬠BIOTECHNOLOGY
Terra Metals Ltd is a AU-based company operating in Metals & Mining industry. The company is headquartered in Perth, Western Australia. The company went IPO on 2012-12-20. Terra Metals Limited, formerly GCX Metals Limited, is a diversified critical metals explorer focused on exploring and developing its Western Australian projects. The firm is primarily focused on the exploration of its flagship Dante Cu-PGE-Au-Ni project in Western Australia. The Dante Project contains large-scale magmatic copper-gold (and palladium-nickel) targets, as well as extensive outcropping PGE-Au-Cu reefs and is situated in the same geological complex and 15 kilometers (km) from the 390 metric tons (Mt) Nebo-Babel nickel-copper deposit and 10km from the 120 Mt Succoth copper deposit. The company is also conducting exploration activities at its Onslow Cu-Au Project and the Southern Cross Li-REE Project in Western Australia. The Onslow Project covers over 548 square kilometers (km2) and comprises three tenements located in the northwestern extension of the Capricorn Orogen. The Southern Cross Project comprises four tenements covering approximately 800km2 in Koolyanobbing shear zone.
π Performance (5Yr p.a)
-6.52%
π Share price
$0.03 AUD
βοΈ MINING
Telstra Group Ltd. engages in the provision of telecommunications and technology services. The company is headquartered in Melbourne, Victoria and currently employs 33,761 full-time employees. The firm's Telstra Consumer segment provides telecommunication and technology products and services to consumer customers in Australia using mobile and fixed network technologies. Its Telstra Business segment provides telecommunication and technology products and services to small and medium businesses. Its Telstra Enterprise Australia segment provides telecommunication services, advanced technology solutions and others. Its Telstra International segment provides telecommunication, media and technology products and services to consumer, business and government customers in the South Pacific through its Digicel Pacific business. Its Networks, IT and Product segment's operations include Global Networks and Technology, and Product and Technology. Its Telstra InfraCo segment provides telecommunication products and services delivered over its networks.
π Performance (5Yr p.a)
1.52%
π Share price
$3.90 AUD
π COMMUNICATIONS